← Back to headlines
Immunic CEO Discusses Q2 Progress and Phase 3 MS Trial Milestones
The CEO of Immunic provided an update on the company's progress in the second quarter and highlighted key milestones achieved in its Phase 3 multiple sclerosis trial.
10 Aug, 19:07 — 10 Aug, 19:07
Sources
Showing 1 of 1 sources
Related Stories
Jakarta Airport Halts Operations Due to Volcanic Ash From Anak Krakatau
36m ago
US-Russia Talks on Ukraine End with Constructive Tone but No Breakthrough
1h ago
Trump Threatens Trade Restrictions Over Federal Reserve Rate Decisions
2h ago
PM Modi Defends India’s 7.8% GDP Growth Amid Opposition Criticism
2h ago